FBIO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Fortress Biotech Inc (FBIO).


$55.90M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

FBIO Market Cap. (MRY)


FBIO Shares Outstanding (MRY)


FBIO Assets (MRY)


Total Assets

$144.22M

Total Liabilities

$145.87M

Total Investments

$0

FBIO Income (MRY)


Revenue

$57.67M

Net Income

-$46.00M

Operating Expense

$147.18M

FBIO Cash Flow (MRY)


CF Operations

-$80.19M

CF Investing

-$15.00M

CF Financing

$70.64M

FBIO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

FBIO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$144,223,000 (-13.91%)

$167,526,000 (-43.08%)

$294,301,000 (-25.78%)

$396,503,000 (18.92%)

Assets Current

$90,371,000 (-22.77%)

$117,022,000 (-49.22%)

$230,432,000 (-33.49%)

$346,462,000 (30.18%)

Assets Non-Current

$53,852,000 (6.63%)

$50,504,000 (-20.93%)

$63,869,000 (27.63%)

$50,041,000 (-25.60%)

Goodwill & Intangible Assets

$31,863,000 (57.06%)

$20,287,000 (-25.41%)

$27,197,000 (116.67%)

$12,552,000 (-14.20%)

Shareholders Equity

$22,737,000 (0.86%)

$22,544,000 (-45.96%)

$41,721,000 (-61.61%)

$108,674,000 (8.31%)

Property Plant & Equipment Net

$17,121,000 (-27.13%)

$23,495,000 (-28.83%)

$33,011,000 (-3.11%)

$34,071,000 (5.12%)

Cash & Equivalents

$58,815,000 (-29.45%)

$83,365,000 (-53.93%)

$180,954,000 (-41.24%)

$307,964,000 (31.05%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$2,611,000 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$14,431,000 (41.40%)

$10,206,000 (-27.92%)

$14,159,000 (43.57%)

$9,862,000 (602.42%)

Trade & Non-Trade Receivables

$10,402,000 (-32.41%)

$15,389,000 (-45.71%)

$28,346,000 (19.15%)

$23,790,000 (-3.57%)

Trade & Non-Trade Payables

$65,501,000 (-10.96%)

$73,562,000 (-24.51%)

$97,446,000 (7.49%)

$90,660,000 (99.74%)

Accumulated Retained Earnings (Deficit)

-$740,867,000 (-6.62%)

-$694,870,000 (-9.56%)

-$634,233,000 (-15.85%)

-$547,463,000 (-13.40%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$932,000 (10.56%)

$843,000 (0%)

$0 (0%)

$345,000 (0%)

Total Debt

$75,335,000 (-11.98%)

$85,592,000 (-29.12%)

$120,749,000 (80.65%)

$66,840,000 (-12.53%)

Debt Current

$2,623,000 (-59.36%)

$6,454,000 (-13.33%)

$7,447,000 (155.38%)

$2,916,000 (57.71%)

Debt Non-Current

$72,712,000 (-8.12%)

$79,138,000 (-30.15%)

$113,302,000 (77.24%)

$63,924,000 (-14.27%)

Total Liabilities

$145,867,000 (-12.10%)

$165,939,000 (-32.07%)

$244,276,000 (43.16%)

$170,626,000 (25.08%)

Liabilities Current

$71,399,000 (-15.91%)

$84,908,000 (-33.52%)

$127,715,000 (26.40%)

$101,042,000 (95.21%)

Liabilities Non-Current

$74,468,000 (-8.10%)

$81,031,000 (-30.48%)

$116,561,000 (67.51%)

$69,584,000 (-17.80%)

FBIO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$57,675,000 (-31.76%)

$84,513,000 (11.58%)

$75,743,000 (10.11%)

$68,791,000 (50.86%)

Cost of Revenue

$20,879,000 (-21.68%)

$26,660,000 (-13.37%)

$30,775,000 (-4.08%)

$32,084,000 (119.84%)

Selling General & Administrative Expense

$87,731,000 (-6.79%)

$94,124,000 (-17.19%)

$113,656,000 (30.88%)

$86,843,000 (41.98%)

Research & Development Expense

$56,881,000 (-46.37%)

$106,071,000 (-21.36%)

$134,876,000 (4.66%)

$128,865,000 (101.01%)

Operating Expenses

$147,175,000 (-26.48%)

$200,195,000 (-19.45%)

$248,532,000 (10.34%)

$225,248,000 (79.80%)

Interest Expense

$13,527,000 (-11.67%)

$15,315,000 (12.26%)

$13,642,000 (-10.88%)

$15,308,000 (-0.12%)

Income Tax Expense

$312,000 (-40.12%)

$521,000 (16.04%)

$449,000 (-5.07%)

$473,000 (247.79%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$120,855,000 (21.60%)

-$154,154,000 (27.94%)

-$213,913,000 (-29.78%)

-$164,826,000 (-60.05%)

Net Income to Non-Controlling Interests

-$74,858,000 (19.95%)

-$93,517,000 (26.56%)

-$127,338,000 (-27.18%)

-$100,123,000 (-77.34%)

Net Income

-$45,997,000 (24.14%)

-$60,637,000 (29.96%)

-$86,575,000 (-33.80%)

-$64,703,000 (-39.07%)

Preferred Dividends Income Statement Impact

$9,893,000 (23.17%)

$8,032,000 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$55,890,000 (18.61%)

-$68,669,000 (20.68%)

-$86,575,000 (-33.80%)

-$64,703,000 (-39.07%)

Weighted Average Shares

$20,784,334 (156.25%)

$8,110,906 (36.89%)

$5,924,968 (8.78%)

$5,446,681 (13.46%)

Weighted Average Shares Diluted

$20,784,334 (156.25%)

$8,110,906 (36.89%)

$5,924,968 (8.78%)

$5,446,681 (13.46%)

Earning Before Interest & Taxes (EBIT)

-$32,158,000 (28.22%)

-$44,801,000 (38.19%)

-$72,484,000 (-48.16%)

-$48,922,000 (-57.49%)

Gross Profit

$36,796,000 (-36.40%)

$57,853,000 (28.65%)

$44,968,000 (22.51%)

$36,707,000 (18.39%)

Operating Income

-$110,379,000 (22.46%)

-$142,342,000 (30.08%)

-$203,564,000 (-7.97%)

-$188,541,000 (-100.00%)

FBIO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$15,000,000 (-613.27%)

-$2,103,000 (90.83%)

-$22,928,000 (-156.59%)

$40,514,000 (665.52%)

Net Cash Flow from Financing

$70,641,000 (115.77%)

$32,739,000 (-56.53%)

$75,319,000 (-49.45%)

$148,994,000 (-13.58%)

Net Cash Flow from Operations

-$80,191,000 (37.46%)

-$128,225,000 (28.53%)

-$179,401,000 (-53.94%)

-$116,540,000 (-39.27%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$24,550,000 (74.84%)

-$97,589,000 (23.16%)

-$127,010,000 (-274.06%)

$72,968,000 (-10.54%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$20,000,000 (-135.17%)

$56,860,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$5,937,000 (329.40%)

-$2,588,000 (47.89%)

-$4,966,000 (-58.86%)

Issuance (Repayment) of Debt Securities

-$7,330,000 (81.21%)

-$39,004,000 (-180.17%)

$48,651,000 (599.86%)

-$9,733,000 (71.48%)

Issuance (Purchase) of Equity Shares

$21,239,000 (-11.94%)

$24,119,000 (432.55%)

$4,529,000 (-51.63%)

$9,363,000 (-79.66%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$32,619,000 (91.55%)

$17,029,000 (-25.92%)

$22,987,000 (17.97%)

$19,486,000 (44.87%)

Depreciation Amortization & Accretion

$7,310,000 (-9.47%)

$8,075,000 (59.08%)

$5,076,000 (17.58%)

$4,317,000 (10.55%)

FBIO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

63.80% (-6.86%)

68.50% (15.32%)

59.40% (11.24%)

53.40% (-21.47%)

Profit Margin

-96.90% (-19.19%)

-81.30% (28.87%)

-114.30% (-21.47%)

-94.10% (7.75%)

EBITDA Margin

-43.10% (0.92%)

-43.50% (51.12%)

-89.00% (-37.35%)

-64.80% (-8.72%)

Return on Average Equity (ROAE)

-263.60% (8.31%)

-287.50% (-131.11%)

-124.40% (-99.68%)

-62.30% (1.27%)

Return on Average Assets (ROAA)

-38.40% (-6.67%)

-36.00% (-44.58%)

-24.90% (-55.62%)

-16.00% (3.03%)

Return on Sales (ROS)

-55.80% (-5.28%)

-53.00% (44.62%)

-95.70% (-34.60%)

-71.10% (-4.41%)

Return on Invested Capital (ROIC)

-58.00% (38.75%)

-94.70% (-14.65%)

-82.60% (-77.25%)

-46.60% (-71.32%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.75 (-112.11%)

-0.35 (47.41%)

-0.68 (78.67%)

-3.17 (-42.76%)

Price to Sales Ratio (P/S)

0.73 (152.60%)

0.29 (-62.42%)

0.77 (-74.10%)

2.97 (-40.69%)

Price to Book Ratio (P/B)

2.46 (105.95%)

1.19 (-29.97%)

1.71 (-25.61%)

2.29 (-22.57%)

Debt to Equity Ratio (D/E)

6.42 (-12.85%)

7.36 (25.72%)

5.86 (272.93%)

1.57 (15.44%)

Earnings Per Share (EPS)

-2.69 (68.24%)

-8.47 (41.79%)

-14.55 (-22.78%)

-11.85 (44.76%)

Sales Per Share (SPS)

2.77 (-73.37%)

10.42 (-18.49%)

12.78 (1.22%)

12.63 (32.96%)

Free Cash Flow Per Share (FCFPS)

-3.86 (74.41%)

-15.08 (50.91%)

-30.72 (-37.69%)

-22.31 (-23.36%)

Book Value Per Share (BVPS)

1.09 (-60.63%)

2.78 (-60.54%)

7.04 (-64.71%)

19.95 (-4.55%)

Tangible Assets Book Value Per Share (TABVPS)

5.41 (-70.22%)

18.15 (-59.73%)

45.08 (-36.05%)

70.49 (6.15%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (-100.00%)

-1 (0%)

0 (0%)

-1 (80.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.63 (-317.49%)

-0.63 (-272.80%)

0.36 (122.78%)

-1.6 (71.63%)

Asset Turnover

0.4 (-10.38%)

0.44 (103.21%)

0.22 (27.49%)

0.17 (5.56%)

Current Ratio

1.27 (-8.13%)

1.38 (-23.61%)

1.8 (-47.39%)

3.43 (-33.31%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$80,191,000 (34.42%)

-$122,288,000 (32.80%)

-$181,989,000 (-49.78%)

-$121,506,000 (-39.97%)

Enterprise Value (EV)

$65,262,991 (182.31%)

$23,117,681 (194.29%)

-$24,518,018 (-134.39%)

$71,295,490 (-53.39%)

Earnings Before Tax (EBT)

-$45,685,000 (24.01%)

-$60,116,000 (30.20%)

-$86,126,000 (-34.09%)

-$64,230,000 (-38.46%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$24,848,000 (32.34%)

-$36,726,000 (45.52%)

-$67,408,000 (-51.12%)

-$44,605,000 (-64.24%)

Invested Capital

$57,481,000 (-10.96%)

$64,558,000 (-18.47%)

$79,184,000 (89.50%)

$41,785,000 (-61.47%)

Working Capital

$18,972,000 (-40.92%)

$32,114,000 (-68.74%)

$102,717,000 (-58.15%)

$245,420,000 (14.47%)

Tangible Asset Value

$112,360,000 (-23.69%)

$147,239,000 (-44.88%)

$267,104,000 (-30.43%)

$383,951,000 (20.44%)

Market Capitalization

$55,899,991 (107.67%)

$26,917,681 (-62.16%)

$71,142,982 (-71.44%)

$249,073,490 (-16.15%)

Average Equity

$21,199,250 (-11.23%)

$23,880,750 (-65.70%)

$69,618,500 (-32.98%)

$103,878,750 (40.78%)

Average Assets

$145,409,500 (-23.70%)

$190,586,250 (-45.15%)

$347,436,750 (-13.87%)

$403,384,250 (43.22%)

Invested Capital Average

$55,430,500 (17.14%)

$47,320,500 (-46.05%)

$87,719,250 (-16.48%)

$105,025,500 (-7.93%)

Shares

27,604,934 (208.69%)

8,942,751 (23.50%)

7,241,016 (9.02%)

6,641,960 (6.32%)